Viewing Study NCT01174511



Ignite Creation Date: 2024-05-05 @ 10:45 PM
Last Modification Date: 2024-10-26 @ 10:23 AM
Study NCT ID: NCT01174511
Status: UNKNOWN
Last Update Posted: 2011-07-06
First Post: 2010-08-02

Brief Title: Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
Sponsor: Hadassah Medical Organization
Organization: Hadassah Medical Organization

Study Overview

Official Title: Clinical Trial Study for Evaluation of A-1 Cool Cream Efficacy for Treatment Patients With Atopic Dermatitis
Status: UNKNOWN
Status Verified Date: 2010-07
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Atopic dermatitis AD is a chronic inflammatory skin disease affecting 20 of all babies and children around the world Diagnosis of atopic dermatitis is clinical and depends on the existence of at least two out of the four following criteria itching a chronic disease course with exacerbations and remission rash with characteristic distribution and shape atopia of the patient or family by history

Initial treatment is based on keeping skin moist and avoiding a flare-provoking stimuli and allergens The research product A-1 COOL is a skin cream approved by the Israeli Ministry of Health for cooling down of skin irritation A-1 COOL is rich in herbal medicine ingredients and does not contain steroidsA-1 COOL can be beneficial in Atopic Dermatitis patients due to its following action mechanisms sealing of the inflamed skin and retention of water prevention of the itching cycle by keeping the skin moist disinfection of the skin by the herbal ingredients
Detailed Description: Atopic dermatitis AD is a chronic inflammatory skin disease affecting 20 of all babies and children around the world In 90 of the cases the disease first appears before the age of five and in 65 of the cases it is already apparent at infancy but it may occur at any age

Diagnosis of atopic dermatitis is clinical and depends on the existence of at least two out of the four following criteria itching a chronic disease course with exacerbations and remission rash with characteristic distribution and shape atopia of the patient or family by history

Initial treatment is based on keeping skin moist and avoiding a flare-provoking stimuli and allergens Topical ointments which grease the skin have shown and reduction of skin inflammation These products can include active substances such as steroids and anti-inflammatory compounds

Systemic treatments for atopic dermatitis mainly include steroids and cyclosporine

The research product A-1 COOL is a skin cream approved by the Israeli Ministry of Health for cooling down of skin irritation A-1 COOL is rich in herbal medicine ingredients and does not contain steroidsA-1 COOL can be beneficial in Atopic Dermatitis patients due to its following action mechanisms sealing of the inflamed skin and retention of water prevention of the itching cycle by keeping the skin moist disinfection of the skin by the herbal ingredients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None